135 related articles for article (PubMed ID: 2512655)
1. A comparative study of standard and slow-release oral lithium carbonate products.
Wallis J; Miller R; McFadyen ML; Carlile JB
S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
[TBL] [Abstract][Full Text] [Related]
2. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
Castrogiovanni P
Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
[TBL] [Abstract][Full Text] [Related]
3. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
Thornhill DP
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
[TBL] [Abstract][Full Text] [Related]
4. [Slow-release lithium carbonate versus standard preparation in bipolar affective disorders (author's transl)].
Bohacek N; Mihovilović M
Lijec Vjesn; 1980 Oct; 102(10):575-9. PubMed ID: 6790888
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
Johnson GF; Hunt GE; Lewis J; St George B
Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
[TBL] [Abstract][Full Text] [Related]
6. Aspect of the pharmacokinetics of slow-release lithium carbonate.
Hart GA
S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
[TBL] [Abstract][Full Text] [Related]
7. Absorption of lithium following administration of slow-release and conventional preparations.
Tyrer S; Hullin RP; Birch NJ; Goodwin JC
Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lithium preparations in patients.
Johnson GF; Hunt GE
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
[TBL] [Abstract][Full Text] [Related]
9. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
Arancibia A; Corvalan F; Mella F; Concha L
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
[TBL] [Abstract][Full Text] [Related]
10. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
Kauko K; Viukari M
Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
[No Abstract] [Full Text] [Related]
11. [Administration of a slow-acting lithium preparation (preliminary report)].
Molchan I; Motylova A; Khalabala I
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1241-3. PubMed ID: 899543
[No Abstract] [Full Text] [Related]
12. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum bromide in patients taking lithium carbonate.
Handorf CR; Coleman JH; Rawls WN
J Clin Psychiatry; 1985 Jan; 46(1):9-10. PubMed ID: 3917430
[TBL] [Abstract][Full Text] [Related]
14. [Use of long-acting lithium carbonate--micalite--in the treatment of affective psychoses].
Khvilivitskiĭ TIa; Mikhalenko IN; Zlatikina GN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(4):583-7. PubMed ID: 868433
[TBL] [Abstract][Full Text] [Related]
15. Intensive treatment with lithium carbonate "once a day" in bipolar patients.
Tondo L; Tagliamonte A; Ghiani C; Mercenaro S
Clin Ter; 2001; 152(5):277-80. PubMed ID: 11794846
[TBL] [Abstract][Full Text] [Related]
16. Appropriateness of therapeutic drug monitoring for lithium.
Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of contemnol tablets (lithium retard Spofa)].
König L; Lange E
Psychiatr Neurol Med Psychol (Leipz); 1987 Apr; 39(4):230-3. PubMed ID: 3110815
[TBL] [Abstract][Full Text] [Related]
18. Unrecognized delayed toxic lithium peak concentration in an acute poisoning with sustained release lithium product.
Borrás-Blasco J; Sirvent AE; Navarro-Ruiz A; Murcia-López A; Romero-Crespo I; Enriquez R
South Med J; 2007 Mar; 100(3):321-3. PubMed ID: 17396741
[TBL] [Abstract][Full Text] [Related]
19. The long-term efficacy and tolerability of carbolithium once a day: an interim analysis at 6 months.
Durbano F; Mencacci C; Dorigo D; Riva M; Buffa G
Clin Ter; 2002; 153(3):161-6. PubMed ID: 12161976
[TBL] [Abstract][Full Text] [Related]
20. [Use of individual pharmacokinetic parameters in establishing a regimen for lithium administration].
Pop RD; Leucuţa SE; Domuţa M; Fodoreanu L; Barna D; Kovacs A; Gabor S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(3):223-7. PubMed ID: 6239352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
